A new heterologous fibrin sealant as scaffold to recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins for the repair of tibial bone defects

被引:37
作者
Machado, Eduardo Gomes [1 ]
Mardegan Issa, Joao Paulo [2 ]
Tocchini de Figueiredo, Fellipe Augusto [2 ]
dos Santos, Geovane Ribeiro [1 ]
Galdeano, Ewerton Alexandre [1 ]
Alves, Mariana Carla [1 ]
Chacon, Erivelto Luis [1 ]
Ferreira Junior, Rui Seabra [3 ]
Barraviera, Benedito [3 ]
da Cunha, Marcelo Rodrigues [1 ]
机构
[1] Sch Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil
[2] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Stomatol & Physiol, BR-14040904 Ribeirao Preto, SP, Brazil
[3] Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
关键词
Fibrin; Sealant; Scaffold; BMP-2; Natural latex; Protein P-1; SNAKE-VENOM; GLUE; CELL; COMPOSITES; VIABILITY; BMP-2;
D O I
10.1016/j.acthis.2015.03.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tissue engineering has special interest in bone tissue aiming at future medical applications Studies have focused on recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins due to the osteogenic properties of rhBMP-2 and the angiogenic characteristic of fraction 1 protein (P-1) extracted from the rubber tree Hevea brasiliensis. Furthermore, heterologous fibrin sealant (FS) has been shown as a promising alternative in regenerative therapies. The aim of this study was to evaluate these substances for the repair of bone defects in rats. A bone defect measuring 3 mm in diameter was created in the proximal metaphysis of the left tibia of 60 rats and was implanted with rhBMP-2 or P-1 in combination with a new heterologous FS derived from snake venom. The animals were divided into six groups: control (unfilled bone defect), rhBMP-2 (defect filled with 5 mu g rhBMP-2), P-1 (defect filled with 5 mu g P-1), FS (defect filled with 8 mu g FS), FS/rhBMP-2 (defect filled with 8 mu g FS and 5 mu g rhBMP-2), FS/P-1 (defect filled with 8 mu g FS and 5 mu g P-1). The animals were sacrificed 2 and 6 weeks after surgery. The newly formed bone projected from the margins of the original bone and exhibited trabecular morphology and a disorganized arrangement of osteocyte lacunae. Immunohistochemical analysis showed intense expression of osteocalcin in all groups. Histometric analysis revealed a significant difference in all groups after 2 weeks (p < 0.05), except for the rhBMP-2 and FS/rhBMP-2 groups (p > 0.05). A statistically significant difference (p < 0.05) was observed in all groups after 6 weeks in relation to the volume of newly formed bone in the surgical area. In conclusion, the new heterologous fibrin sealant was found to be biocompatible and the combination with rhBMP-2 showed the highest osteogenic and osteoconductive capacity for bone healing. These findings suggest a promising application of this combination in the regeneration surgery. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 37 条
  • [31] Autologous mesenchymal stem cell implantation, hydroxyapatite, bone morphogenetic protein-2, and internal fixation for treating critical-sized defects: a translational study
    Dilogo, Ismail Hadisoebroto
    Phedy, Phedy
    Kholinne, Erica
    Djaja, Yoshi Pratama
    Fiolin, Jessica
    Kusnadi, Yuyus
    Yulisa, Nyimas Diana
    [J]. INTERNATIONAL ORTHOPAEDICS, 2019, 43 (06) : 1509 - 1519
  • [32] Effect on cochlea function of guinea pig after controlled release recombinant human bone morphogenetic protein 2 transplanted into the middle ear
    Li Xue-sheng
    Sun Jian-jun
    Jiang Wei
    Liu Xiao
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (01) : 84 - 88
  • [33] Evaluation of Bone Regenerative Capacity in Rabbit Femoral Defect Using Thermally Disinfected Bone Human Femoral Head Combined with Platelet-Rich Plasma, Recombinant Human Bone Morphogenetic Protein 2, and Zoledronic Acid
    Saginova, Dina
    Tashmetov, Elyarbek
    Kamyshanskiy, Yevgeniy
    Tuleubayev, Berik
    Rimashevskiy, Denis
    [J]. BIOMEDICINES, 2023, 11 (06)
  • [34] Bone formation of middle ear cavity using biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 using animal model
    Kim, Sung Eun
    Yun, Young-Pil
    Song, Hae-Ryong
    Choi, Kyung-Hee
    Kim, Bo Hae
    Lee, Eun Kyeung
    Song, Jae-Jun
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2013, 77 (09) : 1430 - 1433
  • [35] Influence of low-level laser associated with osteogenic proteins recombinant human BMP-2 and Hevea brasiliensis on bone repair in Wistar rats
    Iyomasa, Mamie Mizusaki
    Mardegan Issa, Joao Paulo
    de Queiroz Tavares, Mirella Lemos
    Lara Pereira, Yamba Carla
    Sasso Stuani, Maria Bernadete
    Mishima, Fabiola
    Coutinho-Netto, Joaquim
    Sebald, Walter
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2012, 75 (02) : 117 - 125
  • [36] Cost-Utility Analysis of 1-and 2-Level Dorsal Lumbar Fusions With and Without Recombinant Human Bone Morphogenic Protein-2 at 1-Year Follow-Up
    Alvin, Matthew D.
    Derakhshan, Adeeb
    Lubelski, Daniel
    Abdullah, Kalil G.
    Whitmore, Robert G.
    Benzel, Edward C.
    Mroz, Thomas E.
    [J]. CLINICAL SPINE SURGERY, 2016, 29 (01): : E28 - E33
  • [37] Synergistic effects of stromal cell-derived factor-1α and bone morphogenetic protein-2 treatment on odontogenic differentiation of human stem cells from apical papilla cultured in the VitroGel 3D system
    Xiao, Min
    Qiu, Jun
    Kuang, Rong
    Zhang, Beidi
    Wang, Wei
    Yu, Qing
    [J]. CELL AND TISSUE RESEARCH, 2019, 378 (02) : 207 - 220